COVID-19 and SARS-CoV-2 Antibodies in Multiple Sclerosis Patients

NCT04498286 · clinicaltrials.gov ↗
COMPLETED
Status
546
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Zoé van Kempen